We analyzed WBCC trends in TRial Of Preventing HYpertension ( TROPHY ) to determine if this inflammatory marker predicted incident hypertension in prehypertensive individuals and whether randomized assignment to the ARB candesartan ( 391 individuals ) for 2 years , lowered WBCC compared with placebo-treated controls ( 381 individuals ) .